A single dose study in healthy subjects demonstrating pharmacokinetic and pharmacodynamic equivalence between MK-1293 and EU- and US-approved innovator insulin glargineM. Hompesch,J. Palcza, K. Mostoller, C. Mahon, A. M. Barbour,Y. Xu, E. Mangin, P. Algatt-Bergstrom,L. Morrow, M. CrutchlowDIABETOLOGIA（2015）引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
